IMMUNOME INC (IMNM)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for IMNM
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IMNM | Director | 62 | ["more than 25 years of experience in healthcare investment banking and equity capital markets","Managing Partner at Hyphen Advisors, LLC","Vice Chair, Equity Capital Markets at Wells Fargo Securities","Vice President of Finance and Business Development at Lexicon Pharmaceuticals, Inc.","Managing Director of Equity Capital Markets at J.P. Morgan","board member of Insmed Incorporated, Kura Oncology, Inc.","former board member of Five Prime Therapeutics, Repare Therapeutics Inc., and Idera Pharmaceuticals, Inc.","M.B.A. from New York University’s Stern School of Business","B.A. from Boston College"] | ["Audit (Chair)","Nominating and Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| INSM | Director | 62 | ["more than 30 years of experience in investment banking, corporate finance and business development", "significant experience in financing and equity capital markets in the pharmaceutical and biotechnology industries", "recent cybersecurity training"] | ["Audit", "Compensation", "Audit Committee", "Nominations and Governance Committee"] | 2026 |